Overall survival and prognostic factors prostate cancer in Kurdistan Province-Iran: a population-based study (2011-2018) | BMC Cancer | Full Text
PLOS ONE: Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer
ASCO GU 2022: The Changing Landscape of Treatment and Survival for Men with Castration-Resistant Prostate Cancer in the Era of Novel Treatments
PLOS ONE: Overall survival and second primary malignancies in men with metastatic prostate cancer
Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model - European Urology
Overall survival rate of patients with T3a and T3b stage prostate... | Download Scientific Diagram
ANO7 rs77559646 Is Associated With First-line Docetaxel Treatment Response in Metastatic Castration-resistant Prostate Cancer | Anticancer Research
SciELO - Brasil - Prostate cancer incidentally discovered at the time of radical cystoprostatectomy does not decrease overall survival: Results from a large Chinese medical center Prostate cancer incidentally discovered at the
Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era - International Journal of Radiation Oncology, Biology, Physics
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
Overall survival of black and white men with metastatic castration-resistant prostate cancer (mCRPC): a 20-year retrospective analysis in the largest healthcare trust in England | Prostate Cancer and Prostatic Diseases
Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel? - Clinical Genitourinary Cancer
Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry.,Prostate Cancer and Prostatic Diseases - X-MOL
Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer - European Urology
Predicting Time From Metastasis to Overall Survival in Castration-Resistant Prostate Cancer: Results From SEARCH - ScienceDirect
prostate cancer and hormones
Kaplan-Meier analysis of overall survival among prostate cancer... | Download Scientific Diagram
Overall survival and prostate cancer specific-survival according to... | Download Scientific Diagram
Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer - Annals of Oncology
A) Progression-free survival and (B) overall survival in... | Download Scientific Diagram
Oncotarget: Melatonin increases overall survival of prostate cancer patients | Oncotarget
Olaparib for Metastatic Castration-Resistant Prostate Cancer | NEJM
Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database | Scientific Reports
Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data - The Lancet Oncology
Comparison of clinical and survival characteristics between prostate cancer patients of PSA-based screening and clinical diagnosis in China | Oncotarget
